| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Chronic Hepatitis C
[description not available] | 0 | 3 | 1 | 0 |
Chemical Dependence
[description not available] | 0 | 3 | 1 | 0 |
Alcohol Drinking
Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. | 0 | 3 | 1 | 0 |
Porphyria Cutanea Tarda
An autosomal dominant or acquired porphyria due to a deficiency of UROPORPHYRINOGEN DECARBOXYLASE in the LIVER. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type I is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type II is the familial form. | 0 | 3 | 1 | 0 |
Hepatitis C, Chronic
INFLAMMATION of the LIVER in humans that is caused by HEPATITIS C VIRUS lasting six months or more. Chronic hepatitis C can lead to LIVER CIRRHOSIS. | 0 | 3 | 1 | 0 |
Substance-Related Disorders
Disorders related to substance use or abuse. | 0 | 3 | 1 | 0 |
Chronic Kidney Failure
[description not available] | 0 | 1.96 | 1 | 0 |
Porphyria
[description not available] | 0 | 2.88 | 4 | 0 |
Bullous Dermatoses
[description not available] | 0 | 1.96 | 1 | 0 |
Kidney Failure, Chronic
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. | 0 | 1.96 | 1 | 0 |
Porphyrias
A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues. | 0 | 2.88 | 4 | 0 |
Dermatoses
[description not available] | 0 | 1.97 | 1 | 0 |
Skin Diseases
Diseases involving the DERMIS or EPIDERMIS. | 0 | 1.97 | 1 | 0 |